Thanks John, I guess i have used the wrong wording but the thrust of my post in short, how big is this opportunity across so many facets.
How do we get a strong level of assurance that each has got adequate incremental protection, if there is a thing.
My knowledge of biotech IP is zip as just demonstrated.
What you gave in response is appreciated and just highlights to me that each and every different use of Bis will require separate lodgements.
So I have invested absolutely naked of IP protection. Huge risk. So that answers the question about the absence institutional and professional investment.
Surely the shareholders should have an announcement declaring some level of comfort as Race moves forward with each level of development/advsncement
Hope you aren’t offended by my prattling.
RAC Price at posting:
$1.52 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)